Literature DB >> 20861614

The role of tumor necrosis factor-α converting enzyme in renal transplant rejection.

Jun Wang1, Zilong Li, Rafia Al-Lamki, Juan Wang, Nan Zuo, John R Bradley, Lining Wang.   

Abstract

BACKGROUND: Tumor necrosis factor receptors (TNFR) are differentially regulated in human rejecting renal transplants. The TNF-α converting enzyme (TACE) regulates the membrane shedding of both receptors and TNF itself. We analyzed the expression and regulation of TACE in human rejecting renal transplants.
METHODS: Samples from normal renal tissue or renal transplant undergoing severe acute rejection were immunostained for TACE using antibodies from different species. Human kidney epithelial cells were cultured and TACE plasmid was transfected to upregulate TACE expression. Cells were fractionated and immunoblotted for TACE, and ELISA was performed to test soluble TNFR2.
RESULTS: We showed that TACE was upregulated mainly in tubular epithelial cells in acute rejecting kidney, where it colocalized with TNFR2. Epithelial cells with increased levels of TACE shed more soluble TNFR2 into culture media and even more after TACE activation by phorbol-12-myristate-13-acetate stimulation. The shedding could be completely blocked by the TACE inhibitor TNF-α protease inhibitor.
CONCLUSION: Upregulation of TACE in epithelial cells in acute rejecting kidney could lead to more TNFR2 shedding and, hence, antagonize the proinflammatory effect of local TNF.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861614     DOI: 10.1159/000320467

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  5 in total

1.  Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease.

Authors:  Hong Jiang; Harald Hampel; David Prvulovic; Anders Wallin; Kaj Blennow; Rena Li; Yong Shen
Journal:  Mol Neurodegener       Date:  2011-10-06       Impact factor: 14.195

Review 2.  Tumor necrosis factor receptor 2: its contribution to acute cellular rejection and clear cell renal carcinoma.

Authors:  Jun Wang; Rafia S Al-Lamki
Journal:  Biomed Res Int       Date:  2013-11-17       Impact factor: 3.411

3.  TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells.

Authors:  Jun Wang; Rafia S Al-Lamki; Xinwang Zhu; Hanzhe Liu; Jordan S Pober; John R Bradley
Journal:  BMC Nephrol       Date:  2014-11-16       Impact factor: 2.388

Review 4.  TFNR2 in Ischemia-Reperfusion Injury, Rejection, and Tolerance in Transplantation.

Authors:  Araz Kouyoumdjian; Jean Tchervenkov; Steven Paraskevas
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

Review 5.  Mining the Biomarker Potential of the Urine Peptidome: From Amino Acids Properties to Proteases.

Authors:  Fábio Trindade; António S Barros; Jéssica Silva; Antonia Vlahou; Inês Falcão-Pires; Sofia Guedes; Carla Vitorino; Rita Ferreira; Adelino Leite-Moreira; Francisco Amado; Rui Vitorino
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.